Journals in Biomedical engineering

4 results in All results

Biochemical Engineering Journal

• ISSN: 1369-703X
• 5 Year impact factor: 3.5
• Impact factor: 3.7

endorsed by Division of Biochemical Engineering, The Society of Chemical Engineers, JapanBiochemical Engineering Journal welcomes submissions from NIH-funded authors. We deposit gold open access articles immediately in PubMed Central. For other articles, we shall deposit the accepted manuscript on behalf of the author to PubMed Central after 12 months (the normal embargo period for this journal is 24 months). For more information, please see here.The Biochemical Engineering Journal aims to promote progress in the crucial chemical engineering aspects of the development of biological processes associated with everything from raw materials preparation to product recovery relevant to industries as diverse as medical/healthcare, industrial biotechnology, and environmental biotechnology.The Journal welcomes full length original research papers, short communications, and review papers* in the following research fields:Biocatalysis (enzyme or microbial) and biotransformations, including immobilized biocatalyst preparation and kinetics Biosensors and Biodevices including biofabrication and novel fuel cell development Bioseparations including scale-up and protein refolding/renaturation Environmental Bioengineering including bioconversion, bioremediation, and microbial fuel cellsBioreactor Systems including characterization, optimization and scale-up Bioresources and Biorefinery Engineering including biomass conversion, biofuels, bioenergy, and optimization Industrial Biotechnology including specialty chemicals, platform chemicals and neutraceuticalsBiomaterials and Tissue Engineering including bioartificial organs, cell encapsulation, and controlled release Cell Culture Engineering (plant, animal or insect cells) including viral vectors, monoclonal antibodies, recombinant proteins, vaccines, and secondary metabolites Cell Therapies and Stem Cells including pluripotent, mesenchymal and hematopoietic stem cells; immunotherapies; tissue-specific differentiation; and cryopreservation Metabolic Engineering, Systems and Synthetic Biology including OMICS, bioinformatics, in silico biology, and metabolic flux analysis Protein Engineering including enzyme engineering and directed evolution*Authors are requested to complete a Review Proposal Form for Editorial approval prior to submission of the review article. Proposals can be submitted to [email protected] or one of the Editors.

Subscribe

Biocybernetics and Biomedical Engineering

• ISSN: 0208-5216
• 5 Year impact factor: 5.6
• Impact factor: 5.3

Biocybernetics and Biomedical Engineering is a quarterly journal, founded in 1981, devoted to publishing the results of original, innovative and creative research investigations in the field of Biocybernetics and biomedical engineering, which bridges mathematical, physical, chemical and engineering methods and technology to analyse physiological processes in living organisms as well as to develop methods, devices and systems used in biology and medicine, mainly in medical diagnosis, monitoring systems and therapy. The Journal's mission is to advance scientific discovery into new or improved standards of care, and promotion a wide-ranging exchange between science and its application to humans. Biocybernetics and Biomedical Engineering encourages contributions on all aspects of research and developments in: biosystems, including biomedical modeling; cell and tissue engineering for repair medicine; biomeasurements, including biosignal processing and biosensing systems; artificial and hybrid (bioartificial) organs; biomaterials; biomechanics and rehabilitation, including orthopedics and sports medicine; medical information systems and neuronal networks; information and communication technologies in medicine, including brain-computer interfaces; medical imaging, including brain functional magnetic resonance imaging (fMRI); bioinformatics, including genome analysis; and medical physics.The journal welcomes original research articles, reviews and short communications.Biocybernetics and Biomedical Engineering (BBE) is the official journal of the Nalecz Institute of Biocybernetics and Biomedical Engineering of the Polish Academy of Sciences.Please see our Guide for Authors for information on article submission.Benefits to authorsWe also provide many author benefits, such as free PDFs, special discounts on Elsevier publications and much more. Please click here for more information on our author services .

Subscribe

Biomaterials

• ISSN: 0142-9612
• 5 Year impact factor: 13.1
• Impact factor: 12.8

Biomaterials is an international journal covering the science and clinical application of biomaterials. A biomaterial is now defined as a substance that has been engineered to take a form which, alone or as part of a complex system, is used to direct, by control of interactions with components of living systems, the course of any therapeutic or diagnostic procedure. It is the aim of the journal to provide a peer-reviewed forum for the publication of original papers and authoritative review and opinion papers dealing with the most important issues facing the use of biomaterials in clinical practice. The scope of the journal covers the wide range of physical, biological and chemical sciences that underpin the design of biomaterials and the clinical disciplines in which they are used. These sciences include polymer synthesis and characterization, drug and gene vector design, the biology of the host response, immunology and toxicology and self assembly at the nanoscale. Clinical applications include the therapies of medical technology and regenerative medicine in all clinical disciplines, and diagnostic systems that reply on innovative contrast and sensing agents. The journal is relevant to areas such as cancer diagnosis and therapy, implantable devices, drug delivery systems, gene vectors, bionanotechnology and tissue engineering.Click here for New Editorial Instructions.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support CenterBiomaterials is the flagship title in Elsevier's biomaterials science portfolio; it sits alongside Materials Today Bio, Biomaterials Advances and Biomaterials and Biosystems . As part of the broader Materials Today family, Biomaterials offers authors rigorous peer review, rapid decisions, and high visibility. We look forward to receiving your submissions!

Subscribe

Biomedical Signal Processing and Control

• ISSN: 1746-8094
• 5 Year impact factor: 4.9
• Impact factor: 4.9

The Official Journal of the European Alliance of Medical and Biological Engineering and Science (EAMBES).Biomedical Signal Processing and Control aims to provide a cross-disciplinary international forum for the interchange of information on research in the measurement and analysis of signals and images in clinical medicine and the biological sciences. Emphasis is placed on contributions dealing with the practical, applications-led research on the use of methods and devices in clinical diagnosis, patient monitoring and management.Biomedical Signal Processing and Control reflects the main areas in which these methods are being used and developed at the interface of both engineering and clinical science. The scope of the journal is defined to include relevant review papers, technical notes, short communications and letters. Tutorial papers and special issues will also be published.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscribe